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Ca2+The present work investigates the mechanisms involved in the vasorelaxant effect of ent-16α-methox-
ykauran-19-oic acid (KA–OCH3), a semi-synthetic derivative obtained from the kaurane-type diterpene ent-
kaur-16-en-19-oic acid (kaurenoic acid). Vascular reactivity experiments were performed in aortic rings
isolated from male Wistar rats using standard muscle bath procedures. The cytosolic calcium concentration
([Ca2+]c) was measured by confocal microscopy using the ﬂuorescent probe Fluo-3 AM. Blood pressure
measurements were performed in conscious rats. KA–OCH3 (10, 50 and 100 μmol/l) inhibited phenylephrine-
induced contraction in either endothelium-intact or endothelium-denuded rat aortic rings. KA–OCH3 also
reduced CaCl2-induced contraction in a Ca2+-free solution containing KCl (30 mmol/l) or phenylephrine
(0.1 μmol/l). KA–OCH3 (0.1–300 μmol/l) concentration-dependently relaxed endothelium-intact and endo-
thelium-denuded aortas pre-contracted with either phenylephrine or KCl, to a greater extent than kaurenoic
acid. Moreover, a Ca2+ mobilisation study showed that KA–OCH3 (100 μmol/l) inhibited the increase in Ca2+
concentration in smooth muscle and endothelial cells induced by phenylephrine or KCl. Pre-incubation of
intact or denuded aortic rings with NG-nitro-L-arginine methyl ester (L-NAME, 100 μmol/l), 7-nitroindazole
(100 μmol/l), wortmannin (0.5 μmol/l) and 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 μmol/l)
produced a rightward displacement of the KA–OCH3 concentration–response curve. Intravenous adminis-
tration of KA–OCH3 (1–10 mg/kg) reduced mean arterial blood pressure in normotensive rats. Collectively,
our results show that KA–OCH3 induces vascular relaxation and hypotension. The mechanisms underlying the
cardiovascular actions of KA–OCH3 involve blockade of Ca2+ inﬂux and activation of the NO-cGMP pathway.lo, Escola de Enfermagem de
902, Ribeirão Preto, SP, Brazil.
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Diterpenoids form a large class of plant-derived secondary
metabolites that possess a wide spectrum of important biological
activities. Many reports have shown that several classes of diterpe-
noids exert signiﬁcant cardiovascular effects (Hipólito et al., 2009;Tirapelli et al., 2004a,b; Tirapelli et al., 2008a; Tirapelli et al., 2010).
The rationale for the study of the cardiovascular actions of diterpenes
is based on the fact that many medicinal plants contain diterpenoids
and that their cardiovascular activity can most likely be attributed to
these compounds (Baccelli et al., 2005; El Bardai et al., 2003).
Somova et al. (2001) showed that the kaurane ent-kaur-16-en-15-
one-19-oic acid reduces vascular resistance via inhibition of extra-
cellular Ca2+ inﬂux. Similarly, ent-kaur-16-en-19-oic acid (kaurenoic
acid) inhibited extracellular Ca2+ inﬂux and induced vascular
relaxation (Tirapelli et al., 2002; Tirapelli et al., 2004a). The relaxant
effect of kaurenoic acid also involves the activation of the nitric oxide
(NO)-cGMP pathway (Tirapelli et al., 2004a). Intravenous adminis-
tration of ent-kaur-16-en-19-oic acid and ent-kaur-16-en-15-one-19-
oic acid at 10 mg/kg in normotensive rats produced an immediate
decrease in systolic blood pressure (by 17 and 18%, respectively),
without changing diastolic blood pressure, and a signiﬁcant decrease
Fig. 1. Chemical structure of ent-kaur-16(17)-en-19-oic acid (kaurenoic acid; left) and
ent-16α-methoxykauran-19-oic acid (KA–OCH3; right).
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Similar results were obtained in our laboratory with ent-kaur-16-en-
19-oic acid (15 mg/kg, i.v.), which was found to decrease mean
arterial pressure in conscious normotensive rats (Tirapelli et al.,
2008b).
It is interesting to note that the mechanisms underlying the
cardiovascular action of kaurane-type diterpenes involve multiple
actions on various targets (Tirapelli et al., 2004a). Structural
differences amongst diterpenes could explain these diverse mecha-
nisms of action; we previously demonstrated that slight modiﬁcations
in the chemical structure of these compounds alter their vascular
effects (Ambrosio et al., 2004; Müller et al., 2003; Tirapelli et al.,
2005). In fact, Zamilpa et al. (2002) demonstrated that the inhibitory
effect displayed by ent-beyer-15-en-19-oic acid on electrically
induced contractions of guinea-pig ileum is more pronounced than
that of kaurenoic acid. The structure of this compound differs slightly
from that of kaurenoic acid because of changes in ring D, such as the
relative stereochemistry, the presence of a double bond between C-15
and C-16, the attachment of a methyl group to C-13 and the lack of an
exocyclic methylene group at C-16. These results provided new
insight into the structure-activity relationship of the kauranes
because it was shown that these changes in ring D account for
improvements in the antispasmodic effect elicited by kaurane-type
diterpenes. Based on such ﬁndings, we hypothesised that structural
alterations could improve the cardiovascular activity of kaurane-type
diterpenes. To test our hypothesis, kaurenoic acid, a naturally
occurring diterpene, was chemically modiﬁed. The semi-synthetic
derivative obtained, the diterpene ent-16α-methoxykauran-19-oic
acid (KA–OCH3), differs from kaurenoic acid because of the insertion
of an α-methoxy group in ring D at C-16. This compound was tested
for its cardiovascular activity.
2. Materials and methods
2.1. Synthesis of KA–OCH3
Eight drops of concentrated H2SO4 were added to a solution of ent-
kaur-16(17)-en-19-oic acid (kaurenoic acid; 200.0 mg; 0.66 mmol) in
methanol (10 ml). Kaurenoic acid was isolated from the dried leaves of
Mikania hirsutissima (1 kg), which were purchased from Nutri
Comércio de Ervas LTDA, São Paulo, SP, Brazil. The mixture was stirred
at 25 °C for 18 h and then poured intowater (40 ml) and extractedwith
ethyl acetate (3× 20 ml). The combined organic layer was dried over
MgSO4, ﬁltered and concentrated in a rotary evaporator to yield
150.0 mg of ent-16α-methoxykauran-19-oic acid (KA–OCH3). This
compound was puriﬁed using “ﬂash” chromatography (Still et al.,
1978), with n-hexane/ethyl acetate (9:1 v/v) as the mobile phase, and
identiﬁed by means of spectrometric analysis and comparison with
data from the literature (Boeck et al., 2005). Kaurenoic acid and
KA–OCH3 were evaluated by TLC using different solvent systems.
According to these results and to their 1H and 13C NMR spectra, we
concluded that the purity of these compounds was suitable for
biological assays. Analysis of the chemical structure of both diterpenes
showed that KA–OCH3 differs from kaurenoic acid only by the insertion
of an α-methoxy group at C-16 (Fig. 1).
2.2. Vessel ring preparation
Male Wistar rats weighting between 200 and 250 g (50–60 days
old) were anaesthetised and killed by aortic exsanguination in
accordance with the Ethical Animal Committee of the Campus of
Ribeirão Preto — University of São Paulo. The thoracic aorta was
quickly removed, cleaned of adherent connective tissues and cut into
rings (5–6 mm in length). Two stainless-steel stirrups were passed
through the lumen of each ring. One stirrup was connected to an
isometric force transducer (TRI201; Panlab, Spain) to measure tensionin the vessels. The rings were placed in a 5 ml organ chamber that
contained Krebs solution, gassed with 95% O2/5% CO2 maintained at
37 °C. The composition of Krebs solution was as follows (mmol/l):
NaCl, 118.0; KCl, 4.7; KH2PO4, 1.2; MgSO4, 1.2; NaHCO3, 15.0; Glucose,
5.5; CaCl2, 2.5. The rings were stretched until they reached a basal
tension of 1.5 g, whichwas determined by length-tension relationship
experiments and were then allowed to equilibrate for 60 min; during
this time, the bath ﬂuid was changed every 15–20 min. For some
rings, the endothelium was removed mechanically by gently rolling
the lumen vessel on a thin wire. Endothelial integrity was assessed
qualitatively by the degree of relaxation caused by acetylcholine
(1 μmol/l) in the presence of contractile tone induced by phenyleph-
rine (0.1 μmol/l). For studies of endothelium-intact vessels, a ring was
discarded if relaxation with acetylcholine was not 80% or greater. For
studies of endothelium-denuded vessels, a ring was discarded if there
was any degree of relaxation.
2.3. Determination of the time-sensitive effects of KA–OCH3
Endothelium-intact rings were contracted with KCl at 30 mmol/l
(control) and then washed out and pre-incubated with KA–OCH3 (10,
50 or 100 μmol/l) for 30 or 60 min. Subsequently, a new stimulation
was performed with KCl at 30 mmol/l on the same ring; each ring
served as its own control. Vessel rings from the same animal that were
not exposed to the diterpene served as time controls.
2.4. Effect of KA–OCH3 on contractions induced by phenylephrine and
CaCl2
After equilibration, cumulative concentration–response curves for
phenylephrine (10 nmol/l to 10 μmol/l) were determined. The curves
were obtained in endothelium-intact and endothelium-denuded rings
by a stepwise increase in the concentration of phenylephrine.
Additions were made as soon as a steady response was obtained at
the preceding concentration. The curves for phenylephrine were
determined without pre-incubation (control group) or after a 30-min
incubation with KA–OCH3 (10, 50 or 100 μmol/l).
To assess the effects of KA–OCH3 on CaCl2-induced contractions,
endothelium-denuded ringswere ﬁrst contractedwith phenylephrine
(0.1 μmol/l) in a Ca2+-free solution containing EGTA (1 mmol/l) for
approximately 90 min to deplete the intracellular Ca2+ stores and
then rinsed in a Ca2+-free solution (without EGTA) containing KCl
(30 mmol/l) or phenylephrine (0.1 μmol/l) (Hipolito et al., 2009). The
cumulative concentration–response curves for CaCl2 (0.05–2 mmol/l)
were obtained without pre-incubation (control group) or after a
30 min incubation period with KA–OCH3 (10, 50 or 100 μmol/l).
2.5. Inﬂuence of KA–OCH3 on Ca
2+ release from intracellular stores
sensitive to phenylephrine and caffeine
To investigate whether KA–OCH3 could interfere with Ca2+ release
from intracellular stores, the normal Krebs solution was replaced with
a Ca2+-free solution containing EGTA (1 mmol/l). The rings were
exposed to this solution for 1 min (David et al., 2002) and were then
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The contractions induced by both agonists were obtained without
pre-incubation (control group) or after a 30-min incubation period
with KA–OCH3 (10, 50 or 100 μmol/l).
2.6. Effect of KA–OCH3 on aortic rings contracted with phenylephrine or
KCl
In another set of experiments, steady tension was evoked by
phenylephrine (concentrations of 0.1 μmol/l for endothelium-intact
rings and 0.03 μmol/l for endothelium-denuded rings were used to
induce contractions of similar magnitude), and KA–OCH3 was then
added in a stepwise fashion (0.1–300 μmol/l). The effect of KA–OCH3 on
KCl-induced sustained contraction (30 mmol/l) in intact or denuded
rings was also examined. For comparison, the effects of kaurenoic acid
(1–450 μmol/l) and verapamil (1 nmol/l to 100 μmol/l), a blocker of
voltage-dependent Ca2+ channels on the contractions induced by
phenylephrine and KCl in endothelium-intact and endothelium-
denuded rings were also evaluated. The cumulative concentration–
response curves were obtained using stepwise increases in the
concentrations of KA–OCH3, kaurenoic acid or verapamil. Additions
were made as soon as a steady response was obtained at the preceding
concentration.
To investigate the possiblemechanism(s) responsible for KA–OCH3-
induced relaxation, endothelium-intact or denuded rings were con-
tracted with phenylephrine (0.1 μmol/l and 0.03 μmol/l, respectively)
30 min after being incubatedwith one of the following drugs: NG-Nitro-
L-arginine methyl ester (L-NAME, 100 and 300 μmol/l), wortmannin
(0.5 and 1 μmol/l), 7-nitroindazole (100 μmol/l), N-([3-(Aminomethyl)
phenyl]methyl)ethanimidamide dihydrochloride (1400W, 1 μmol/l),
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 and 3 μmol/l),
indomethacin (10 μmol/l) and tetraethylammonium (1 mmol/l). Re-
laxation was expressed as percentage change from the phenylephrine-
contracted levels. Because L-NAME and ODQ enhanced phenylephrine-
induced contraction, the rings with intact endothelium exposed to
these compoundswere pre-contractedwith phenylephrine (0.03 μmol/
l) to induce a magnitude of contraction similar to that found in the
intact rings not exposed to the inhibitors.
2.7. Confocal microscopy and image analysis
To image arterial cross sections, the rings (150 μm thick) were
placed vertically onto a coverslip covered with poly-L-lysine. The
tissue was loaded with the ﬂuorescent Ca2+ dye Fluo-3 AM by
incubation in normal Krebs solution containing 10 μmol/l Fluo-3 AM
(Hipolito et al., 2009) for 1 h at room temperature. After washing, the
segment was placed in a chamber with a volume of 1 ml. The chamber
was placed on the stage of a confocal microscope, and images were
taken from the bottom of the chamber through a water-immersion
objective (63×). Ca2+ images of the aortic ring segment were taken
sequentially once every 1.5 s in Krebs solution (pH 7.4). The cytosolic
Ca2+-concentration ([Ca2+]c) was assessed by confocal scanning laser
microscope (Leica TCS SP5). Fluo-3 AM ﬂuorescence was excited with
the 488-nm line of an argon ion laser, and the emitted ﬂuorescence
was measured at 510 nm. Time course software was used to capture
images of the cells at intervals of 1.5 s (xyt) in Live Data Mode
acquisition at 512×512 pixel and 700 Hz. The protocol was designed
tomeasure [Ca2+]c in slices of rat aorta with intact endothelium. Ca2+
concentration was measured in vascular smooth muscle and
endothelial cells in the absence and in the presence of phenylephrine
(10 μmol/l) or KCl (60 mmol/l). In another set of experiments, [Ca2+]c
was measured in slices of rat aorta that were pre-incubated with
verapamil (1 μmol/l, a voltage-dependent Ca2+ channels blocker) or
KA–OCH3 (100 μmol/l). Verapamil and KA–OCH3 were incubated for
30 min before the application of phenylephrine or KCl. Using the
LSCM software, the intensities of the maximum and minimumintracellular ﬂuorescence were measured. In this way, the percentage
of the difference in ﬂuorescence intensity (%ΔFI), which reﬂects the
increase in [Ca2+]c, was obtained for each sample in relation to the
control (100%) using the following equation:
%ΔF = F−F0 = F0ð Þ × 100 ð1Þ
Where F0=the basal ﬂuorescence intensity of Fluo-3 AM and
F=the ﬂuorescence intensity of Fluo-3 AM after stimulation of the
aortic ring with phenylephrine (10 μmol/l) or KCl (60 mmol/l) in the
absence or presence of verapamil (1 μmol/l) or KA–OCH3 (100 μmol/l).
The ﬂuorescence signal used to calculate [Ca2+]i was measured over
the whole cell and was averaged.
2.8. Blood pressure experiments
One day before the experiments, the rats were anesthetised with
tribromoethanol, and a catheter (a 4 cm segment of PE-10 heat-
bound to a 13 cm segment of PE-50, Clay Adams, Parsippany, NJ,
USA) was inserted into the abdominal aorta through the femoral
artery for blood pressure and heart rate recording. A second
catheter was implanted into the femoral vein for intravenous
administration of drugs. Both catheters were implanted under the
skin and exited at the animal's back. During the experiment, freely
moving rats were kept in individual cages, and mean arterial
pressure and heart rate were recorded using an HP-7754A ampliﬁer
(Hewlett Packard, USA) connected to a signal acquisition board
(MP-100, BIOPAC, USA) and processed by a computer. Dose–
response curves for KA–OCH3 and kaurenoic acid were obtained
by bolus intravenous injection of the diterpenes (1–10 mg/kg).
Blood pressure responses were calculated based on the average
mean blood pressure calculated at the response's plateau.
2.9. Drugs
The following drugs were used: phenylephrine hydrochloride,
acetylcholine hydrochloride, verapamil, ODQ, 7-nitroindazole,
1400 W, indomethacin, caffeine, wortmannin, L-NAME, tetraethylam-
monium (Sigma-Aldrich, St. Louis, MO, USA), potassium chloride and
calcium chloride (Synth, São Paulo, Brazil). KA–OCH3, kaurenoic acid,
ODQ, wortmannin and 7-nitroindazole were prepared as stock
solutions in dimethyl sulfoxide (DMSO). Indomethacin was dissolved
in Tris buffer (pH 8.4). The other drugs were dissolved in distilled
water. The bath concentration of DMSO did not exceed 0.5%, which
was shown to have no effect per se on the basal tonus of the
preparations or on the agonist-mediated contraction or relaxation. For
the in vivo experiments, KA–OCH3 was diluted in 10% DMSO and then
in saline. The concentration of DMSO in the ﬁnal solution had no
effects per se on basal cardiovascular parameters (mean arterial
pressure and heart rate), as previously observed (Tirapelli et al.,
2008c).
2.10. Statistical analysis
To study the effect of KA–OCH3 on contraction/relaxation, two
pharmacological parameters were analysed: Emax (maximal effect
generated by the agonist) and pD2 (−log EC50). The following
equation was to calculate Emax and pD2:
Y = Bottom + Top–Bottom½ = ½1 + 10^½ logEC50 X½ 
where X is the logarithm of the concentration and Y is the response. A
plot of Y versus X going from the bottom to the top has a sigmoid
shape. Blood pressure results were expressed as Δ mean arterial
pressure (mm Hg) and Δ heart rate (bpm). Results were expressed as
means±standard errors of the mean (S.E.M.). Statistical analysis of
Table 2
Effect of KA–OCH3 on the Emax (g) and pD2 values for phenylephrine in endothelium-
intact (Endo+) or denuded (Endo−) aortic rings.
KA–OCH3
[μmol/l]
Emax pD2
Endo+ Endo− Endo+ Endo−
0 1.45±0.10 (10) 1.76±0.10 (6) 7.84±0.28 8.30±0.16
10 1.25±0.10a (6) 1.31±0.15a (8) 7.48±0.23 7.74±0.30
50 1.00±0.06a (11) 1.10±0.09a (5) 7.00±0.09a 7.53±0.17a
100 0.82±0.07a,b (11) 1.00±0.18a,b (5) 6.95±0.07a,b 7.47±0.10a
Number between parentheses indicates the number of animals. Values aremeans±S.E.M.
a Compared to control group.
b Compared to KA–OCH3 10 μmol/l (ANOVA followed by Newman–Keuls multiple
comparison test, Pb0.05).
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performed using one-way analysis of variance (ANOVA). The same
analysis was applied to the blood pressure experiments. Post-hoc
comparisons were performed after ANOVA analysis using a Newman–
Keuls multiple comparison test as indicated in the text and tables. For
all analyses, P values of less than 0.05 were considered signiﬁcant.
3. Results
3.1. Determination of the time-dependent effects of KA–OCH3
No differences in the contraction induced by KCl (30 mmol/l) at
different time points were detected (data not shown). KA–OCH3
inhibited the contraction induced by KCl in a concentration-
dependent manner. However, no differences were found between
the two periods of incubation (Table 1), indicating that KA–OCH3
achieved its maximal inhibitory action at 30 min (equilibrium
period). Based on these ﬁndings, the 30-min period of incubation
was chosen to study the mechanisms underlying the vascular action
displayed by KA–OCH3.
3.2. Effect of KA–OCH3 on contractions induced by phenylephrine and
CaCl2
The chemical structures of KA–OCH3 and kaurenoic acid are
represented in Fig. 1. The Emax values for phenylephrine in both
endothelium-intact and endothelium-denuded rings were reduced in
the presence of KA–OCH3 at 10, 50 and 100 μmol/l. KA–OCH3 reduced
the pD2 values for phenylephrine in both endothelium-intact and
endothelium-denuded rings (Table 2).
As shown in Fig. 2, pre-treatment of the rings with KA–OCH3
attenuated CaCl2-induced contraction in denuded rat aortas exposed
to Ca2+-free medium containing KCl. Pre-incubation of the rings with
KA–OCH3 at 10, 50 or 100 μmol/l signiﬁcantly reduced the Emax values
for CaCl2 (Table 3). CaCl2-induced contraction in Ca2+-free medium
containing phenylephrine was attenuated by KA–OCH3 at doses of 50
and 100 μmol/l (Fig. 2, Table 3).
3.3. Inﬂuence of KA–OCH3 on Ca
2+ release from intracellular stores
The results presented in Table 4 show that the contractions
induced by phenylephrine or caffeine in Ca2+-free solution were not
affected by KA–OCH3.
3.4. Effect of KA–OCH3 on aortic rings pre-contracted with phenylephrine
or KCl
KA–OCH3, at concentrations ranging from 0.1 to 300 μmol/l,
signiﬁcantly reduced the sustained contractions induced by phenyleph-
rine and KCl in a concentration-dependent manner (Fig. 3). The Emax
values (percentage of relaxation) for the relaxant effect of KA–OCH3 inTable 1
Percentage inhibition induced by KA–OCH3 on KCl-induced contraction of endotheli-
um-intact rat aorta after different periods of incubation.
Minutes KA–OCH3
10 μmol/l 50 μmol/l 100 μmol/l
30 20.1±1.1 a (5) 47.5±3.4 a,b (4) 68.7±2.8a,b,c (4)
60 17.9±1.2 a (4) 55,2±2.6 a,b (4) 70.3±7.1a,b,c (4)
Number between parentheses indicates the number of animals. Values are means±
S.E.M. The rings were initially stimulated with KCl 30 mmol/l (control group, 100%
contraction) and a second stimulation was performed after incubation with KA–OCH3.
a Signiﬁcant difference from control (0% inhibition).
b Signiﬁcant difference from KA–OCH3 at 10 μmol/l.
c Signiﬁcant difference from KA–OCH3 at 50 μmol/l (ANOVA followed by Newman–
Keuls multiple comparison test, pb0.05).endothelium-intact and endothelium-denuded rings pre-contracted
with phenylephrine were not signiﬁcantly different (80.6±2.8%,
n=10 and 80.8±6.4%, n=6, respectively). Similarly, no differences
were found in the pD2 values for KA–OCH3 in intact or denuded rings
(5.29±0.10 and 5.08±0.07; respectively). In the arteries pre-contracted
with KCl, there was no difference between the Emax values for KA–
OCH3 in intact or denuded rings (85.4±3.9%; n=6 and 85.1±8.0%,
n=6, respectively). The Emax values for KA–OCH3 in the rings pre-
contracted with KCl were not different from those found in
phenylephrine-pre-contracted rings. The pD2 values for KA–OCH3 in
intact and denuded rings pre-contracted with KCl were not signiﬁ-
cantly different (5.27±0.04 and 5.22±0.11, respectively).
The relaxation induced by kaurenoic acid (1–450 μmol/l) in
endothelium-intact and endothelium-denuded rings pre-contracted
with phenylephrine was not signiﬁcantly different (72.3±3.3%, n=7
and 80.1±3%, n=5, respectively) from that found for KA–OCH3
(80.6±2.8%, n=10 and 80.8±6.4%, n=6, respectively). However,
differences were found in the pD2 values for kaurenoic acid in intact or
denuded rings (4.4±0.14 and 4.5±0.12; respectively) when compared
to KA–OCH3 (5.29±0.10 and 5.08±0.07; respectively) (Pb0.05, ANOVA
followed by Newman–Keuls multiple comparison test). In the arteriesFig. 2. Effect of KA–OCH3 on CaCl2-induced contractile response in endothelium-denuded
aortic rings. Concentration–response curves for CaCl2 were determined in Ca2+-free
solution containing phenylephrine (0.1 μmol/l) or KCl (30 mmol/l). The curves were
determined in the absence (control) or after a 30 min period of incubation with KA–OCH3
(10, 50 or 100 μmol/l).
Table 3
Effect of KA–OCH3 on CaCl2-induced contraction in Ca2+-free solution containing
phenylephrine (0.1 μmol/l) or KCl (30 mmol/l).
KA–OCH3
[μmol/l]
Stimulant: phenylephrine Stimulant: KCl
Emax (grammes) pD2 Emax (grammes) pD2
0 1.14±0.10 (5) 0.64±0.08 1.58±0.13 (6) 0.66±0.14
10 1.00±0.12 (7) 0.79±0.11 1.40±0.14 (6) 0.71±0.15
50 0.72±0.10a (7) 0.79±0.10 1.00±0.12a,b(5) 0.64±0.15
100 0.58±0.10a (6) 0.74±0.13 0.88±0.11a,b (6) 0.37±0.11a,b,c
Number between parentheses indicates the number of animals. Values aremeans±S.E.M.
a Compared to control group.
b Compared to KA–OCH3 10 μmol/l.
c Compared to KA–OCH3 50 μmol/l (ANOVA followed by Newman–Keuls multiple
comparison test, Pb0.05).
Fig. 3. Relaxation responses induced by KA–OCH3, kaurenoic acid and verapamil on rat
aortic rings. The relaxation induced by these compounds was studied on endothelium
intact (Endo+) and endothelium denuded (Endo−) rat aortic rings sub-maximally pre-
contracted with either phenylephrine (0.1 μmol/l, left) or KCl (30 mmol/l, right). Steady
tension was evoked by phenylephrine or KCl and then KA–OCH (0.1–300 μmol/l),
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values for kaurenoic acid (74.5±4.8%; n=8 and 78.2±1.3%, n=8,
respectively) and KA–OCH3 in intact and denuded rings (85.4±3.9%;
n=6 and 85.1±8.0%, n=6, respectively). The pD2 values for kaurenoic
acid in intact and denuded rings pre-contractedwith KCl (4.3±0.11 and
4.2±0.1, respectively) were signiﬁcantly different from those found for
KA–OCH3 (5.27±0.04 and 5.22±0.11, respectively) (Pb0.05, ANOVA
followed by Newman–Keuls multiple comparison test).
Fig. 3 shows that the relaxation induced by verapamil in
endothelium-intact (98.8±2.4%, n=6) and endothelium-denuded
(100.4±2.3%, n=8) rings pre-contracted with phenylephrine was
signiﬁcantly different from that observed with KA–OCH3 (80.6±2.8%,
n=10 and 80.8±6.4%, n=6, respectively) (Pb0.05, ANOVA followed
by Newman–Keuls multiple comparison test). The pD2 values for
verapamil in endothelium-intact (pD2=6.3±0.1) and endothelium-
denuded (pD2=6.2±0.2) rings were higher than those obtained using
KA–OCH3 (5.29±0.10 and 5.08±0.07; respectively) (Pb0.05, ANOVA
followed by Newman–Keuls multiple comparison test). Verapamil also
exerted a more pronounced relaxation in intact (102.1±1.1%, n=7)
and denuded (107.1±2.3%, n=7) KCl-pre-contracted aortic rings
when compared with KA–OCH3 in rings with or without endothelium
(85.4±3.9%; n=6 and 85.1±8.0%, n=6, respectively). Again, the pD2
values found for verapamil in intact anddenuded rings (pD2=6.7±0.1;
6.9±0.2) were higher than those obtained for KA–OCH3 in endothe-
lium-intact or endothelium-denuded rings (5.27±0.04 and5.22±0.11,
respectively) (Pb0.05, ANOVA followed by Newman–Keuls multiple
comparison test).3
kaurenoic acid (1–450 μmol/l) or verapamil (10 nmol/l to 100 μmol/l) were added
cumulatively.3.5. Effect of several inhibitors on KA–OCH3-induced relaxation in
phenylephrine pre-contracted rings
There was a rightward displacement of the concentration-response
curve for KA–OCH3 in endothelium-intact and endothelium-denuded
rings in the presence of L-NAME (a non-selective NOS inhibitor),
7-nitroindazole (a selective nNOS inhibitor), wortmannin (a selective
PI3K inhibitor) and ODQ (a selective guanylyl cyclase inhibitor)
(Table 5). At high concentrations, L-NAME and ODQ reduced the
maximal relaxation induced by KA–OCH3. On the other hand, 1400WTable 4
Effect of KA–OCH3 on phenylephrine (1 μmol/l) and caffeine (30 mmol/l)-induced
contraction (g) in Ca2+-free medium.
Contractile agent KA–OCH3 [μmol/l]
0 10 50 100
Phenylephrine 0.63±0.08 0.54±0.09 0.55±0.07 0.64±0.05
Caffeine 0.33±0.04 0.40±0.03 0.36±0.07 0.35±0.04
Values are means±S.E.M., n=5–7 experiments.(a selective iNOS inhibitor), indomethacin (a non-selective cyclooxy-
genase inhibitor) and tetraethylammonium (a non-selective K+
channel blocker) did not have a signiﬁcant effect on KA–OCH3-induced
relaxation in either endothelium-intact or endothelium-denuded rings
(Table 5). The magnitude of contraction induced by phenylephrine was
similar in the presence of the different inhibitors (data not shown).3.6. Confocal microscopy and image analysis
Analysis of our data using Eq. (1) revealed that [Ca2+]c was
signiﬁcantly increased after addition of phenylephrine or KCl to
endothelial cells (Fig. 4). The increase in [Ca2+]c mediated by
phenylephrine or KCl was signiﬁcantly inhibited by verapamil or KA–
OCH3. Similarly, [Ca2+]c was signiﬁcantly increased after addition of
phenylephrine or KCl to smooth muscle cells (Fig. 4). The increase in
[Ca2+]c induced by phenylephrine and KCl in smooth muscle cells was
signiﬁcantly reduced by treatment with verapamil or KA–OCH3.
Table 5
Effect of L-NAME, 7-nitroindazole, 1400 W, ODQ, wortmannin, indomethacin and tetraethylammonium on KA–OCH3-induced relaxant responses (% relaxation) of endothelium-
intact or denuded rat aortic rings pre-contracted with phenylephrine.
Groups Endothelium-intact Endothelium-denuded
Emax pD2 Emax pD2
Control 80.6±2.8 (10) 5.29±0.1 80.8±6.4 (6) 5.08±0.07
L-NAME 100 μmol/l 78.4±6.6 (6) 4.6±0.2a 84.1±4.1 (6) 4.5±0.1a
L-NAME 300 μmol/l 37.3±4.7a (5) 4.7±0.1a 38.4 3.9a (6) 4.7±0.1a
7-nitroindazole 100 μmol/l 74.0±3.4 (5) 4.6±0.1a 84.2±5.4 (6) 4.4±0.1a
1400 W 1 μmol/l 88.8±8.8 (6) 4.9±0.2 86.5±9.1 (5) 4.8±0.2
ODQ 1 μmol/l 81.5±2.5 (7) 4.5±0.1a 85.9±6.7 (6) 4.6±0.13a
ODQ 3 μmol/l 38.2±2.3a (6) 4.7±0.1a 38.1±4.1a (6) 4.7±0.1a
Wortmannin 0.5 μmol/l 81.2±7.1 (7) 4.4±0.1a 68.3±7.7 (7) 4.5±0.1a
Wortmannin 1 μmol/l 72.8±9.9 (6) 4.7±0.2a 67.8±6.4 (6) 4.6±0.1a
Indomethacin 10 μmol/l 83.2±3.5 (8) 5.1±0.1 85.4±4.7 (7) 5.5±0.2
Tetraethylammonium 1 mmol/l 88.1±4.3 (8) 4.9±0.2 93.2±6.3 (5) 4.9±0.2
Number between parentheses indicates the number of animals. Values are means±S.E.M.
a Compared to control group (ANOVA followed by Newman–Keuls multiple comparison test, Pb0.05).
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The maximal variation in mean arterial pressure and heart rate
induced by KA–OCH3 and kaurenoic acid in conscious normotensive rats
is presented in Fig. 5. The basal values for themean arterial pressure and
heart rate were 98±1.7 mm Hg (n=10) and 343±6.5 bpm (n=10),
respectively. A bolus injection of KA–OCH3 or kaurenoic acid (1 to
10 mg/kg) produced a dose-dependent decrease in mean arterial
pressure and an increase in heart rate in conscious normotensive rats.
The mean arterial pressure values returned to basal levels within the
ﬁrst minute after injection of all doses of the diterpenes. KA–OCH3 was
found to be more potent than kaurenoic acid at inducing a decrease in
mean arterial pressure and an increase in heart rate.
4. Discussion
The present ﬁndings corroborate previous studies showing that
alterations in the chemical structure of kauranes modify their
biological actions (Ambrosio et al., 2004; Muller et al., 2003; Zamilpa
et al., 2002). The carboxyl group at C-19 is an important structural
element (Enriquez et al., 1984; Campos-Bedolla et al., 1997) but is not
the only component responsible for the antispasmodic and relaxant
effects of diterpenes (Muller et al., 2003; Ambrosio et al., 2004). In
fact, Zamilpa et al. (2002) showed that ent-beyer-15-en-19-oic acid, a
diterpene that differs slightly from kaurenoic acid in ring D, was more
effective than kaurenoic acid at inhibiting electrically induced
contractions in guinea-pig ileum. In the present study, we showed
that KA–OCH3, a semi-synthetic derivative diterpene that differs from
kaurenoic acid by the insertion of an α-methoxy group in ring D at
C-16, inhibits the vascular contraction induced by phenylephrine and
KCl and induces relaxation in arteries pre-contracted with both
phenylephrine and KCl. However, it is important to note that
KA–OCH3 is approximately ten times more potent than kaurenoic
acid at inducing vascular relaxation. Based in such observations, we
concluded that this chemical modiﬁcation increased kaurenoic acid's
vascular action.
Two types of stimulants are widely used in vascular smooth muscle
to increase the cytosolic Ca2+ level: high-K+-induced membrane
depolarisation and contractile agonists such as phenylephrine (Karaki
et al., 1997). An increase in the cytosolic Ca2+ concentration is themajor
trigger for smooth muscle contraction because it leads to the formation
of the Ca2+-calmodulin complex, inducing signalling that culminates in
muscle contraction (Araujo and Bendhack, 2003). Phenylephrine-
induced contraction is mediated by an increase in Ca2+ inﬂux through
both receptor-operated channels (Hirata et al., 1998) and voltage-
sensitive channels (Wesselman et al., 1996; Lee et al., 2001), whereas
KCl-induced contraction in smooth muscle is mediated by cellmembrane depolarisation and an increase in Ca2+ inﬂux through
voltage-operated Ca2+ channels (Hudgins andWeiss, 1968; Somlyo and
Somlyo, 1994). The present ﬁndings show that KA–OCH3 inhibited the
vascular contraction induced by phenylephrine and KCl (30 mmol/l)
suggesting that KA–OCH3 blocks Ca2+ inﬂux through interference with
both voltage- and receptor-operated channels. Moreover, we observed
that KA–OCH3 induced endothelium-independent relaxation in aortic
rings pre-contractedwith both phenylephrine andKCl and inhibited the
contraction induced by CaCl2 in a Ca2+-free solution containing KCl or
phenylephrine. Finally, using the selective probe Fluo-3 AM, we found
that KA–OCH3 inhibits the increase in [Ca2+]c induced by phenyleph-
rine and KCl. Taken together, our results support the notion that
KA–OCH3 acts as a Ca2+ channel blocker.
The effect of KA–OCH3 on Ca2+ release from phenylephrine- and
caffeine-sensitive intracellular stores was also analysed. In our study,
the magnitude of contraction induced by phenylephrine was higher
than that induced by caffeine. Phenylephrine induces the production
of inositol triphosphate (IP3), which activates IP3 receptors (Eckert et
al., 2000), whilst caffeine stimulates ryanodine receptors (Xu et al.,
1998). Both receptors mediate the release of Ca2+ from the
sarcoplasmic reticulum, an essential step in smooth muscle contrac-
tion. However, in addition to the production of IP3, stimulation of α1
receptors by phenylephrine results in the regulation of multiple
effector systems such as the production of diacylglycerol, which in
turn activates protein kinase C. The latter phosphorylates the light
chain of myosin, which is associated with the development of tension
(Stull et al., 1990). The activation of protein kinase C by phenylephrine
could be responsible for the increase in tension induced by this
agonist compared to caffeine. The lack of effect of KA–OCH3 on Ca2+
release from intracellular stores sensitive to phenylephrine and
caffeine suggests that the vascular effect of the diterpene does not
involve a reduction in Ca2+ release from intracellular stores.
Moreover, this result might explain the fact that KA–OCH3 displayed
similar relaxant responses in preparations pre-contracted with
phenylephrine and KCl. Phenylephrine-induced contraction involves
the opening of Ca2+ channels on the plasma membrane and the
mobilisation of intracellular Ca2+ stores, whilst KCl-induced contrac-
tion is mediated bymembrane depolarisation and the opening of Ca2+
channels on the membrane. Since KA–OCH3 does not affect Ca2+
release from intracellular stores, this compound should act as a
blocker of Ca2+ channels located on the plasma membrane.
Diterpenes exert their cardiovascular effects by acting at multiple
sites (Melis, 1997; Tirapelli et al., 2004a,b). The NO pathway was
described to be involved in the cardiovascular action of some
diterpenes (De Oliveira et al., 2006; Silva et al., 2005a, 2005b). In our
study, pre-treatment of endothelium-intact or endothelium-denuded
rings with L-NAME was associated with a rightward displacement of
408 U.V. Hipólito et al. / European Journal of Pharmacology 660 (2011) 402–410
Fig. 5. Effect of KA–OCH3 and kaurenoic acid (1–10 mg/kg) on mean arterial pressure
and heart rate. Maximal variation in mean arterial pressure (mm Hg) and heart rate
(bpm) induced by intravenous injection of KA–OCH3 or kaurenoic acid was evaluated in
conscious normotensive rats. Each bar represents the mean±S.E.M. of 5 experiments.
*Compared with kaurenoic acid (Pb0.05, ANOVA followed by Newman–Keuls multiple
comparison test).
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vasorelaxant effects of KA–OCH3. Our data suggests that KA–OCH3
induces the generation of NO in smooth muscle, which was
demonstrated to possess biochemical pathways to produce NO
(Carrillo-Sepúlveda et al., 2010; Schini and Vanhoutte, 1991). As NO
synthase is an enzyme that occurs in threemajor isoforms (endothelial,
neuronal and inducible) (Förstermann et al., 1994), we investigated
which of these isoforms is involved in KA–OCH3-induced relaxation.
The rightward displacement of the concentration–response curve for
KA–OCH3 in endothelium-intact and endothelium-denuded rings in the
presence of 7-nitroindazole suggests that the activation of nNOS plays a
role in the vasorelaxant effects of KA–OCH3. nNOS is expressed in
vascular smooth muscle cells (Carrillo-Sepúlveda et al., 2010), and the
phosphatidylinositol 3-kinase (PI3K)/Akt signalling pathway has been
shown to upregulate the phosphorylation of nNOS, activating the
enzyme and promoting vasodilatation (Carrillo-Sepúlveda et al., 2010;
El-Mas et al., 2009). Taken together, our results suggest that the
vasodilator effect of KA–OCH3 is partly mediated by increased
production of NO, which occurs rapidly upon activation of PI3K/Akt
signalling, as suggested by the ability of the PI3K inhibitor wortmannin
to alter KA–OCH3-induced relaxation. Since NO induces relaxation in
vascular smooth muscle through a cGMP-dependent mechanism
(Moncada et al., 1989), we sought to determine a possible requirement
for the cGMP pathway in the vasorelaxant action of KA–OCH3. A
selective inhibitor of guanylyl cyclase enzyme, ODQ (Garthwaite et al.,
1995), inhibited the vasorelaxant action of KA–OCH3; this ﬁnding
conﬁrms the involvement of the NO-cGMP pathway in KA–OCH3-
mediated vasorelaxant responses.Fig. 4. Effect of phenylephrine and KCl on transient [Ca2+]c in the presence of KA–OCH3 or v
and then stimulated with phenylephrine (10 μmol/l) or KCl (60 mmol/l) in the absence (co
images of Fluo-3 AM ﬂuorescence in slices of rat aorta were recorded at the times (t) 0, 3, a
changes of ﬂuorescence intensity (%ΔFI) of [Ca2+]c in vascular smooth muscle cells (VSMC)
phenylephrine or KCl or the combination of these stimulants with verapamil and KA–OCH3
control group (Pb0.05, ANOVA followed by Newman–Keuls multiple comparison test).Vasodilator cyclooxygenase product(s) of non-endothelial origin
have been described to induce endothelium-independent relaxation
(Cherry et al., 1982; Förstermann et al., 1986) and to mediate the
relaxation induced by diterpenes (De Oliveira et al., 2006; Tirapelli et
al., 2004b). Indomethacin, a non-selective cyclooxygenase inhibitor,
was not found to affect the relaxation caused by KA–OCH3. Therefore,
it appears that cyclooxygenase pathways do not play an appreciable
role in mediating KA–OCH3's vasodilatory effects.
The opening of K+ channels in the cell membranes of smooth
muscle cells in arteries increases K+ efﬂux, causing membrane
potential hyperpolarisation, which leads to vasodilatation (Nelson
and Quayle, 1995). Tetraethylammonium, a non-selective blocker of K+
channels, did not alter the relaxation induced by KA–OCH3, ruling out
the participation of K+ channels in the vasorelaxant action induced by
this diterpene. Interestingly, we previously demonstrated that the
vasorelaxation induced by kaurenoic acid involves the opening of K+
channels (Tirapelli et al., 2004a). Based on these ﬁndings, we suggest
that the chemical modiﬁcation of kaurenoic acid to obtain KA–OCH3 not
only increased the potency of the compound but also altered its
mechanism of action. Thus, the present ﬁndings highlight the great
importance of studying other diterpenes in a structure-activity context
to determine which other factors contribute to the antispasmodic and
relaxant activity displayed by this class of compounds.
Several reports show that kaurane-type diterpenes induce hypo-
tension in conscious normotensive rats by a mechanism that involves
blockade of extracellular Ca2+ inﬂux in the vascular smooth muscle
(Somova et al., 2001; Tirapelli et al., 2008a), further indicating that the
hypotensive action displayed by natural occurring diterpenes is
related to their myorelaxant activity. Since KA–OCH3 induces vascular
relaxation, we hypothesised that this diterpene could exert a
hypotensive action. Bolus injection of KA–OCH3 produced a dose-
dependent decrease in mean arterial pressure in conscious normo-
tensive rats. Kaurenoic acid induced a less pronounced decrease in
blood pressure compared to KA–OCH3, supporting the idea that this
chemical modiﬁcation of kaurenoic acid increased its hypotensive
action. The experiments performed on isolated vascular tissues
suggest that KA–OCH3-induced hypotension is mediated by the direct
vasorelaxant action of this diterpene on the vascular smoothmuscle, a
response that involves the blockade of extracellular Ca2+ inﬂux.
Clinically, Ca2+ antagonists are used for the treatment of hypertension
due to their ability to induce smooth muscle relaxation (Sahney,
2006). Thus, based on its vascular effects, we suggest that KA–OCH3
could potentially exert antihypertensive effects in vivo.
In contrast, KA–OCH3 induced an increase in heart rate. Previously,
the diterpene 14-deoxy-11,12-didehydroandrographolide was found
to cause a signiﬁcant decrease in heart rate in normotensive rats (Zhang
et al., 1998). In isolated rat right atria, this diterpene antagonises the
positive chronotropic effect elicited by the β-adrenoreceptor agonist
isoproterenol, which supports the idea that the bradycardic effect
elicited by 14-deoxy-11,12-didehydroandrographolide in vivo is due to
direct β1-adrenoreceptor blockade. In our study, the increase in heart
rate induced by KA–OCH3 was probably due to reﬂex tachycardia.
However, further studies in isolated rat atria should be performed to
verify whether KA–OCH3 displays a direct effect on heart contractility.
The present study, using a combined in vivo and in vitro approach,
shows that KA–OCH3 induces vascular relaxation and hypotension.
The mechanisms underlying the cardiovascular actions of KA–OCH3
involve two distinct actions, 1) blockade of extracellular Ca2+ inﬂux
and 2) activation of the NO-cGMP pathway. Finally, we conclude thaterapamil: slices of aortic rings with endothelium-intact were preloaded with Fluo-3 AM
ntrol) or presence of KA–OCH3 (100 μmol/l) and verapamil (1 μmol/l). (A) Serial Ca2+
nd 4.5 s and KCl or phenylephrine were added at 1.5 s. (B) Histogram shows the mean
and endothelial cells (EC) from aortic rings preloaded with Fluo-3 AM after addition of
. Each bar represents the mean±S.E.M. of 4 experiments. *Compared with respective
410 U.V. Hipólito et al. / European Journal of Pharmacology 660 (2011) 402–410structural alterations can improve the cardiovascular activity of
kaurane-type diterpenes and alter their mechanism of action.
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